Related Experiment Video
Updated: Mar 24, 2026

System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
Published on: April 5, 2017
Interaction of antimicrobial peptide with mycolyl transferase in Mycobacterium tuberculosis
Devjani I Banerjee1, Tejas P Gohil1
1Ashok & Rita Patel Institute of Integrated Study & Research in Biotechnology and Allied Sciences, Adit Campus, New Vallabh Vidhyanagar, Gujarat, India.
Abstract:
It is estimated that about 40% of the Indian population are infected with tuberculosis (TB) and that ∼3,000,000 people die as a result of TB annually. TB is caused by Mycobacterium tuberculosis. In 2011, the World Health Organization declared India as having the highest TB burden worldwide. An important criteria for pathogenicity is the presence of mycolic acid linked to the protective outer membrane of bacteria. Mycolyl transferase catalyzes the transfer of mycolic acid and promotes cell wall synthesis. This is also considered as a novel target for drug-mediated intervention strategies. Here, we have attempted to understand the interaction between the antimicrobial peptide (AMP), dermcidin, and mycolyl transferase in M. tuberculosis using a computational approach. The present study was undertaken in order to elucidate the capability of AMPs to treat this bacteria, which is less sensitive to available antibiotics, and to design a novel method for new therapies.
More Related Videos
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Inhibitors of Bacterial Protein Synthesis
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
Mechanism of Antibiotic Resistance in MRSA
Inhibitors of Gram-positive Cell Wall Synthesis
Gene Regulation in Microbial Communities: Quorum Sensing

